Boonpiyathad Tadech, Chantveerawong Teerapol, Pradubpongsa Panitan, Sangasapaviliya Atik
Division of Allergy and Clinical Immunology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.
J Allergy (Cairo). 2016;2016:4070635. doi: 10.1155/2016/4070635. Epub 2016 Nov 16.
Vitamin D deficiency has been linked to an increased risk of asthma exacerbations. This study aimed to compare vitamin D status during the period of severe asthma exacerbations and investigate if vitamin D supplementation improves asthma control. A total of 47 asthmatic patients and 40 healthy subjects participated in this study. Serum 25-hydroxyvitamin D (25(OH)D), asthma control test (ACT) score, and % predicted peak expiratory flow rate were evaluated in the period with and without severe asthma exacerbations. After that, we provided vitamin D2 supplements to the patients with low vitamin D levels for 3 months. At the period of asthma exacerbation, the prevalence of vitamin D deficiency and insufficiency was 38.29% and 34.04%. There was no significant difference in the levels of serum 25(OH)D with and without asthma exacerbations but the levels were significantly higher in the healthy group. Serum 25(OH)D levels significantly correlated with ACT score. Moreover, vitamin D2 supplementation improved asthma control in uncontrolled asthma group. Hypovitaminosis D was common in asthmatic patients but was not the leading cause of asthma exacerbations. Serum 25(OH)D levels correlated with the ability to control asthma. Improving vitamin D status might be a benefit in uncontrolled asthmatic patients.
维生素D缺乏与哮喘急性发作风险增加有关。本研究旨在比较重度哮喘急性发作期间的维生素D状态,并调查补充维生素D是否能改善哮喘控制情况。共有47名哮喘患者和40名健康受试者参与了本研究。在有和没有重度哮喘急性发作的期间,评估血清25-羟基维生素D(25(OH)D)、哮喘控制测试(ACT)评分以及预计呼气峰值流速百分比。之后,我们为维生素D水平低的患者提供了3个月的维生素D2补充剂。在哮喘急性发作期,维生素D缺乏和不足的患病率分别为38.29%和34.04%。有和没有哮喘急性发作时血清25(OH)D水平无显著差异,但健康组的水平显著更高。血清25(OH)D水平与ACT评分显著相关。此外,补充维生素D2改善了未得到控制的哮喘组的哮喘控制情况。维生素D缺乏在哮喘患者中很常见,但不是哮喘急性发作的主要原因。血清25(OH)D水平与哮喘控制能力相关。改善维生素D状态可能对未得到控制的哮喘患者有益。